One Goal, Four Paths: Comparing COVID-19 Vaccine Pivotal Trial Protocols

 
• By Bridget Silverman

Phase III protocols for COVID-19 vaccine candidates from Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson are similar – but definitely not the same.

Microscopic view of Coronavirus, a pathogen that attacks the respiratory tract. Analysis and test, experimentation. Sars. 3d render

More from Clinical Trials

More from R&D